Oral presentations per session
(including date and time slots)
(preliminary, vers. 22.09.2018)
K1 Opening & Keynote Lecture I (plenary) Sunday, 23 September 2018 13:00-13:45 |
||
Welcome addresses | ||
Application of Human Multi-Organ-Chips to Enhance Safety and Efficacy Assessment in Drug Discovery Reyk Horland Vice-President, TissUse GmbH, DE-Berlin |
||
K2 Keynote Lecture II (plenary) Monday, 24 September 2018 09:00-09:30 |
||
The Netherlands Initiative "Phasing out the Use of Experimental Animals within a 10 Year Period?" Herman B.W.M. Koëter Managing Director, Orange House Partnership, BE-Brussels & Chairman of NCad, the Netherlands National Committee for the protection of animals used for scientific purposes (NCad), NL-The Hague |
||
K3 Keynote Lecture III (plenary) Tuesday, 25 September 2018 09:00-09:30 |
||
Generating Human Organ Models by 3D Bioprinting Jens Kurreck Director, Inst. Biotechnology, Applied Biochemistry, TU Berlin, DE-Berlin |
||
K4 Keynote Lecture IV (plenary) Wednesday, 26 September 2018 09:00-09:30 |
||
Having a Successful Career in in vitro Toxicology: Pillars of Success Helena Kandarova Executive Director, MatTek IVLSL (In Vitro Life Science Laboratories), SK-Bratislava |
||
(The topic 3D Models & Multi-Organ Chips (MOC), Human-Organ-Chips (HOC) is sponsored by the Lush Prize) | ||
1.1 3D Models & Multi-Organ-Chips (MOC), Human-Organ-Chips (HOC) I - Perfusion & Lung Sunday, 23 September 2018 13:50-15.20 |
||
11 | Bioprinting Perfusion-Enabled Liver Equivalents for Advanced Organ-on-a-Chip Applications Tobias Grix, DE-Berlin |
|
70 | Characterization of a lung/liver organ-on-a-chip model David Bovard, CH-Neuchâtel |
|
75 | 3D bioprinting of lung and liver models for viral infection and transduction with viral gene vectors Johanna Berg, DE-Berlin |
|
285 | Lung-on-a-Chip: The interplay of primary human epithelial and endothelial cells improves the alveolar barrier function Andreas Stucki, CH-Bern |
|
231 | Microfluidic engineering of vascular networks by growth factor gradient control Barbara Bachmann, AT-Vienna |
|
1.2 3D Models & Multi-Organ-Chips (MOC), Human-Organ-Chips (HOC) II - Woundhealing - Bone & Skin Monday, 24 September 2018 09:35-11:05 |
||
46 | Development of an in vitro human-based multicomponent 3D joint model as basis for the simulation of an arthritic joint model Alexandra Damerau, DE-Berlin awarded with the YSTA 2018 |
|
50 | Mimicking the initial phase of fracture healing in vitro Moritz Pfeiffenberger, DE-Berlin |
|
148 | Re-epithelialization in Focus: Non-invasive Monitoring of Epidermal Wound Closure in Vitro Using Organotypic Skin Models Lisa Kiesewetter, DE-Würzburg |
|
238 | Cartilage-on-a-Chip: the future of osteoarthritis modeling and drug screening? Julie Rosser, AT-Vienna |
|
228 | Utilization of in vitro and ex vivo wound healing models to address different aspects of cutaneous wound healing and drug testing Johanna Brandner, DE-Hamburg |
|
1.3 3D Models & Multi-Organ-Chips (MOC), Human-Organ-Chips (HOC) III - Specific Organs Monday, 24 September 2018 11:35-13:05 |
||
96 | Retina-on-a-Chip: Merging Organoid and Organ-on-a-Chip technology for complex multi-layer tissue models Kevin Achberger, DE-Stuttgart awarded with the YSTA 2018 |
|
284 | Merging high-content and higher-throughput screening: Microphysiological Organ-on-a-Chip systems integrating human retinal, cardiac and adipose tissue Peter Loskill, DE-Stuttgart |
|
102 | Development of a multi-organ in vitro model of the interactions between liver and cardiac cells under uni-directional dynamic flow Bhumika Singh, GB-Rotherham |
|
211 | Characterization of chemical metabolism in combined skin and liver models over extended and repeated exposure in a multi organ chip device Jochen Kühnl, DE-Hamburg |
|
1.4 3D Models & Multi-Organ-Chips (MOC), Human-Organ-Chips (HOC) IV - Intestinal Systems Tuesday, 25 September 2018 14:00-15:30 |
||
36 | Emulating the Gut-Liver Axis - Organ-on-chip as Translational Tool in Sepsis Research Martin Raasch, DE-Jena |
|
263 | Reconstructed 3D Model of Human Small Intestine for Prediction Of Gastrointestinal Toxicity and Drug Absorption Jan Markus, SK-Bratislava |
|
120 | Human intestinal organoids as model for studying drug transport Tamara Zietek, DE-Cologne |
|
178 | High-throughput, perfused intestinal tubules for real-time assessment of drug-induced barrier disruption Karlijn Wilschut, NL-Leiden |
|
1.5 3D Models & Multi-Organ-Chips (MOC), Human-Organ-Chips (HOC) V - Future Applications Tuesday, 25 September 2018 16:00-17:30 |
||
204 | Tomorrow today: organ-on-a-chip advances towards clinically relevant pharmaceutical and medical in vitro models Peter Ertl, AT-Vienna |
|
278 | Microphysiological flux balance platform unravels the dynamics of drug induced steatosis Muneef Ayyash, IL-Jerusalem |
|
223 | Importance of computational modelling in the design of Organ on a Chip Devices Bhumika Singh, GB-Rotherham |
|
208 | Impact of Spheroidal Age on Drug Toxicity and Diffusivity Christoph Eilenberger, AT-Vienna |
|
275 | 3D Models and Multi-Organ-Chips: Scaffold-free 3D tissue models – from static to microphysiological applications Oliver Frei, CH-Schlieren |
|
2.1 3R Centers in Europe - National and Local Centers - part I Monday, 24 September 2018 14:00-15:30 |
||
271 | The National Centre for the 3Rs Jan Ragan, GB-London |
|
192 | Swiss 3R Competence Centre: Promoting research & education on 3Rs Chantra Eskes, CH-Bern |
|
100 | Towards implementation of the 3Rs in basic research and teaching in Italy: Centro 3R Arti Ahluwalia, IT-Pisa |
|
269 | The Slovak National Platform for 3Rs - SNP 3Rs Helena Kandarova, SK-Bratislava |
|
199 | National Committees under Directive 2010/63/EU and Three Rs centres – complementing one another for a win-win Susanna Louhimies, BE-Brussels |
|
2.2 3R Centers in Europe - National and Local Centers - part II Monday, 24 September 2018 16:00-17:30 |
||
221 | Collaboration and complementarity within Three Rs centres Adelaide Dura, IT-Ispra |
|
216 | Berlin – Bundling 3R Expertise in the German Capital Monika Schäfer-Korting, DE-Berlin |
|
99 | Animal protection and 3R in Switzerland Julika Fitzi-Rathgen, CH-Basel |
|
76 | 3Rs at the University of Zurich Paulin Jirkof, CH-Zurich |
|
113 | 'ICar3R' - a New Interdisciplinary Centre for 3Rs in Animal Research of the Justus Liebig University Giessen Stephanie Krämer, DE-Giessen |
|
196 | MUI animalFree Research Cluster Doris Wilflingseder, AT-Innsbruck |
|
paid advertising |
||
3.1 3Rs in Education and Academia - Creating Awareness by Education and Training to Enhance Animal Welfare in Science Monday, 24 September 2018 09:35-11:05 |
||
240 | Alternative approaches in education provide excellent refinement measures Christa Thöne-Reineke, DE-Berlin |
|
54 | ReThink3R: Design Thinking Workshops for Young Scientists – Awareness and Innovation for the 3Rs Laura Behm, DE-Potsdam awarded with the YSTA 2018 |
|
55 | Practical Guidance in LAS-Continuing Professional Development Pieter Verbost, NL-Utrecht |
|
74 | The Laboratory Animal Science and Welfare course at University of Debrecen Ádám Deák, HU-Debrecen |
|
122 | Animal welfare right from the start: The 3Rs concept as a guiding principle in veterinary training Stephanie Krämer, DE-Giessen |
|
183 | ‘Everyone is responsible’ - animal welfare in the education Györgyi Szabó, HU-Budapest |
|
3.2 3Rs in Education and Academia - Teaching and Applying Alternatives in Education and Training Tuesday, 25 September 2018 09:35-11:05 |
||
147 | Training and Teaching in Substitutive Approaches to Animal Testing: the commitment of Italian Academia Anna Maria Bassi, IT-Genova |
|
98 | Implementation of 3R in veterinary education through virtual patients Lena Vogt, DE-Berlin awarded with the YSTA 2018 |
|
104 | Towards animal -free methods in education and training: Lessons from healthcare Luisa Bastos, BE-Brussels |
|
224 | Lung Simulation – An Alternative Approach to Animal Testing for Applications in Aerosol and Respiratory Research Mathias Forjan, AT-Vienna |
|
111 | Teaching 3R principles in ecotoxicology by performing a problem-based learning project Rita Leitner, AT-Vienna |
|
270 | The Alternatives in Education and Academia: what is happening across EU Candida Nastrucci, IT-Rome |
|
4 Advanced Safety Testing of Cosmetics and Consumer Products Sunday, 23 September 2018 16:00-17:30 |
||
273 | Newly validated 3D skin genotoxicity assays improve safety assessments of cosmetic ingredients Rodger Curren, US-Gaithersburg |
|
265 | Inter-and intra-laboratory reproducibility of the in vitro photo-toxicity test using 3D reconstructed human epidermis model EpiDerm Helena Kandarova, SK-Bratislava |
|
91 | Inconsistent effects of chemical filters in UV/ROS stress cell models Stefanie Hofer, AT-Innsbruck |
|
110 | European Institutions Still Need to Close the Door on Animal-Tested Cosmetics Julia Baines, GB-London |
|
5 Alternatives to Animal Testing in Food Safety, Nutrition and Efficacy Sunday, 23 September 2018 13:50-15:20 |
||
229 | More animal testing for less human safety? How animals continue to suffer for our (novel) food and why oral toxicity tests should be replaced Tilo Weber, DE-Neubiberg |
|
201 | In vitro fluid-dynamic intestinal device as fast and reliable approach for food nutrients permeation tests Silvia Scaglione, IT-Genova |
|
24 | Methodological Improvements and Automation for Better Biodetection of Endocrine Activities In-Vitro Karma Fussell, CH-Lausanne |
|
6 Biological Barriers Tuesday, 25 September 2018 09:35-11:05 |
||
56 | Development of an advanced primary in vitro model of the human small intestine Matthias Schweinlin, DE-Würzburg |
|
189 | iPSC-derived renal proximal tubular cells: development and evaluation for their application in nephrotoxicity studies Anja Wilmes, NL-Amsterdam |
|
107 | An improved in vitro model of the oral mucosa epithelium for biomarker research and transport studies: Optimization by media supplements and airlift cultivation Grace Lin, AT-Vienna |
|
154 | Genetically modified 3D human in vitro lung models Samual Constant, CH-Plan-les-Ouates |
|
212 | Microfluidic strategies for nanomaterial risk assessment at in vitro organ barrier models Mario Rothbauer, AT-Vienna |
|
131 | Human induced pluripotent stem cell based in vitro models of the blood-brain barrier: A promise for the future of drug testing, toxicity and disease modelling Winfried Neuhaus, AT-Vienna |
|
7.1 Disease Models Using HUMAN Cells, Tissues and Organs - Tumors & Other Disease Models Monday, 24 September 2018 16:00-17:30 |
||
2 | A combined in silico-3D lung tumor model to understand network effects of driver mutations for targeted therapy predictions Gudrun Dandekar, DE-Würzburg |
|
237 | Establishment of a New Cholangiocarcinoma Cell Line MUG-CCArly1 Florian Kleinegger, AT-Graz |
|
241 | Investigation on ex-vivo functional interactions between tumor cells and lymphoblastoid cells in chordoma Beate Rinner, AT-Graz |
|
274 | Disease models using human cells: 3D in-vitro models for metabolic diseases show translation in diabetes and liver fibrosis Patrick Guye, CH-Schlieren |
|
253 | Extracellular Vesicles – Mighty Players in Chordoma Communication? Ines Anders, AT-Graz |
|
7.2 Disease Models Using HUMAN Cells, Tissues and Organs - Lung & Infection Tuesday, 25 September 2018 16:00-17:30 |
||
93 | A human lung ex vivo infection model Stefan Hippenstiel, DE-Berlin |
|
168 | Human cell- and tissue-based models of the lungs in state of health and disease Nicole Schneider-Daum, DE-Saarbrücken |
|
173 | Modeling respiratory bacterial infections using in vitro human airway epithelia Samual Constant, CH-Plan-les-Ouates |
|
85 | 3D Epithelial Culture Model to Study Chlamydia Infection Munir Al-Zeer, DE-Berlin |
|
136 | hAELVi cells as an in vitro inflammation model Julia Katharina Metz, DE-Saarbrücken |
|
7.3 Disease Models Using HUMAN Cells, Tissues and Organs - Skin Tumor Models Wednesday, 26 September 2018 11:35-13:05 |
||
219 | Normal human skin and atopic dermatitis models – penetration and efficacy of topical glucocorticoids Monika Schäfer-Korting, DE-Berlin |
|
279 | Human cell-based tumor microenvironment models for improved preclinical drug development Christian Zoschke, DE-Berlin |
|
203 | 3D melanoma skin models: unravelling the effects of the basal membrane and sub-populations of fibroblasts in tumour progression and invasion Abdoel El Ghalbzouri, NL-Leiden |
|
258 | Unusual, innovative, and close to in-vivo: MUG-Mel1 and MUG-Mel2 melanoma cell lines for drug development Beate Rinner, AT-Graz |
|
8.1 Ecotoxicology I - Focus on diverse ecotoxicological endpoints Monday, 24 September 2018 14:00-15:30 |
||
45 | Ecological Threshold for Toxicological Concern (eco-TTC) - Applications for Environmental Risk Assessment in Various Contexts Marlies Halder, IT-Ispra |
|
62 | Prediction of acute fish toxicity of fragrance chemicals: the RTgill-W1 cell assay as a simple, accurate and reliable alternative to the fish in vivo test Lu Hostettler, CH-Dübendorf |
|
146 | FISH on CHIPS: Development of a novel in vitro system of the fish intestine Carolin Drieschner, CH-Dübendorf awarded with the YSTA 2018 awarded with the Young Scientist Best Oral Award 2018 for the second best oral presentation |
|
186 | Predicting chemical impact on fish growth by combining computational modelling with in vitro fish cell line responses Kristin Schirmer, CH-Dübendorf |
|
65 | Using mechanisms of toxic action to classify and predict ester ecotoxicity Pascal Bicherel, FR-L’Isle D’Abeau |
|
8.2 Ecotoxicology II - Focus on metabolism and bioaccumulation Tuesday, 25 September 2018 09:35-11:05 |
||
187 | Ability of three rainbow trout (Onchorhynchus mykiss) cell lines to eliminate benzo(a)pyrene and extrapolation to derive a fish bioconcentration factor Kristin Schirmer, CH-Dübendorf |
|
87 | Xenobiotic metabolism in the fish hepatic cell lines Hepa-E1 and RTH-149, and the gill cell lines RTgill-W1 and G1B: biomarkers of CYP450 activity and oxidative stress Marco Franco, US-Waco awarded with the YSTA 2018 |
|
69 | Comparability of the in vitro RTgutGC (Rainbow trout) intestinal cell line to native gastrointestinal tissue Laura Langan, GB-Plymouth |
|
58 | Tissue specific response of organoids to the model compound pyrene in rainbow trout 3D co-cultures Laura Langan, GB-Plymouth |
|
90 | Development of OECD Test Guidelines and Guidance Document on determination of fish in vitro hepatic clearance Marlies Halder, IT-Ispra |
|
63 | Benchmarking study to support regulatory acceptance of the application of in vitro-in vivo extrapolation to predict the bioaccumulation potential of fragrance chemicals Lu Hostettler, CH-Dübendorf |
|
9 Efficacy and Safety Testing of Drugs, Medical Devices & Biopharmaceutics Monday, 24 September 2018 16:00-17:30 |
||
9 | Using a concerted analysis of corresponding cellular assays to create a complete in vitro bone culture and implant testing system Daniel Seitz, DE-Bayreuth |
|
126 | 3D in vitro cardiac model established from fish larvae for application in pharmacology Bianka Grunow, DE-Dummerstorf |
|
172 | Efficacy testing of antivirals using human upper and small airway epithelia Samual Constant, CH-Plan-les-Ouates |
|
266 | Successful Development and Validation of the EpiDerm In Vitro Skin Irritation Protocol for the Assessment of Medical Devices extracts Helena Kandarova, SK-Bratislava |
|
8 | The Nonclinical Innovation and Patient Safety Initiative (NIPSI): Supporting Human-Based Nonclinical Approaches Through Advances in Law, Policy, Education and Training in the United States Elizabeth Baker, US-Washington |
|
156 | Rapid Development of anti-idiotypic binders using a novel affinity scaffold Toni Hoffmann, GB-Wetherby |
|
10 Free Communications Tuesday, 25 September 2018 11:35-13:05 |
||
105 | Cellular senescence: a response pathway within AOPs? Johannes Grillari, AT-Vienna |
|
137 | Gene edited non-human primates (NHPs) – further ethical challenges. And the responsibility of scientific journals Ismene Fertschai, AT-Graz |
|
12 | Comparative analysis of the difference of toxicity test between Chinese and European Pharmacopoeia Mao Ling Wei, CN-Chengdu |
|
123 | A review of REACH from the animal perspective Katy Taylor, GB-London |
|
11 In Silico Models: Toxicology & Efficacy of Drugs, Chemicals & Cosmetics Tuesday, 25 September 2018 11:35-13:05 |
||
21 | In Silico Tools to Assist the Development of Physiologically-Based Kinetic Models: Identification, Characterisation and Use Judith Madden, GB-Liverpool |
|
22 | Computational Methods for the Prediction of Chemical Toxicity Priyanka Banerjee, DE-Berlin |
|
124 | Modelling oxygen consumption in brain organoids Arti Ahluwalia, IT-Pisa |
|
163 | In-silico tool to design cyp3a5 silensomestm using T-5 substrate and lapatinib as mechanism-based inhibitor Ashwani Sharma, FR-Saint-Grégoire |
|
230 | An in Silico Lung Tumor Model for Drug Efficacy Screening and Optimal Clinical Therapy as Alternative to Animal Testing Meik Kunz, DE-Würzburg awarded with the YSTA 2018 |
|
paid advertising |
||
12 International Progress in 3Rs Research Sunday, 23 September 2018 16:00-17:30 |
||
86 | Predictive Toxicology, Strategies for Implementing New Approaches Outcomes of the 7th Annual Meeting of the American Society for Cellular and Computational Toxicology Erin Hill, US-Gaithersburg |
|
134 | Consensus Ways of Alternative to Animal Testing in China Shu Jun Cheng, CN-Shanghai |
|
7 | 3Rs Centre in Sri Lanka to promote 'Replacement' concept Stefanie Schindler, CH-Bern |
|
INDIA: Launching of a National Society for Alternatives to Animal Experiments Mohammad A. Akbarsha, IN-Tiruchirappalli |
||
13 In vitro Techniques for CNS Toxicity and Disease Studies Tuesday, 25 September 2018 11:35-13:05 |
||
213 | Stem cell-based human blood-brain barrier co-culture models for pre-clinical development Marco Metzger, DE-Würzburg |
|
108 | Advanced human in vitro blood-brain barrier disease models for cerebral ischemia Anna Gerhartl, AT-Vienna |
|
4 | Modelling ischemic stroke injury at the blood-brain barrier in vitro using induced pluripotent stem cells Abraham Alahmad, US-Amarillo |
|
177 | Microfluidic-embedded 3D networks of iPSC-derived neurons and glia, for highly-predictive mechanistic neurotoxicity screening Karlijn Wilschut, NL-Leiden |
|
248 | Microelectrode array (MEA) recordings of neuronal activity as in vitro tool to assess acute and developmental neurotoxicity Remco Westerink, NL-Utrecht |
|
14.1 Refinement & Reduction I- Culture of Care and Translational Research Monday, 24 September 2018 11:35-13:05 |
||
198 | Culture of Care – from words to action Susanna Louhimies, BE-Brussels |
|
94 | Measuring fecal testosterone metabolites in house mice: replacement of invasive techniques Kerstin E- Thonhauser, AT-Vienna |
|
61 | Different cultures of care for lab animals – a comparative study of practices at universities and private research institutions in Denmark Thomas Lund, DK-Frederiksberg |
|
5 | Measuring Culture of Care – a practical example Thomas Bertelsen, DK-Maaloev |
|
81 | Rehoming of former laboratory animals Henriette Bout, NL-Den Haag |
|
226 | Translational failures call for critical appraisal of animal studies Kathrin Herrmann, US-Baltimore |
|
14.2 Refinement & Reduction II - Refinement and Avoidance of Severe Suffering Tuesday, 25 September 2018 14:00-15:30 |
||
10 | Systematic Assessment of Well-Being in Mice for Procedures Using General Anesthesia Katharina Hohlbaum, DE-Berlin |
|
109 | Evaluating tramadol and buprenorphine applied via the drinking water as pain medication in a mouse osteotomy model Mattea Durst, CH-Zurich |
|
209 | Animal Centric Strategies for Severity Assessment and Refinement Lars Lewejohann, DE-Berlin |
|
18 | Focus on severe suffering: how reducing suffering can be a gateway to replacement Elliot Lilley, GB-Horsham |
|
195 | Refinement by systematic severity scorings in animal experiments Kristina Ullmann, DE-Berlin |
|
235 | Minimising suffering in energy deprived rats Majken Dalgaard, DK-Måløv |
|
14.3 Refinement & Reduction III - Increase Transparency and Use Existing Infrastructures to Reduce the Lab Animal Usage Wednesday, 26 September 2018 09:35-11:05 |
||
38 | Sharing is Caring – Update on innovative approaches to share organs and tissues to reduce the lab animal usage Annemarie Lang, DE-Berlin |
|
1 | The elephant in the room: PREPARE before you ARRIVE Adrian Smith, NO-Oslo |
|
112 | It´s time to rethink: learn from negative results in animal based research! Critical Incident Reporting System in Laboratory Animal Science CIRS-LAS.DE Sabine Bischoff, DE-Jena |
|
132 | Promoting transparency in preclinical research: preregistration of preclinical studies on www.preclinicaltrials.eu Mira van der Naald, NL-Utrecht |
|
37 | The Horse as Model for Osteoarthritis Research – Research Tools vs. Stakeholders Annemarie Lang, DE-Berlin |
|
15 Replacement – Advanced Technologies for Implementation of 3Rs Monday, 24 September 2018 14:00-15:30 |
||
64 | Patient-specific, additively manufactured vascular models enabling an animal-free neurointerventional training setup Juliane Kuhl, DE-Hamburg |
|
184 | A biotechnological metabolic activation system – Potential for replacing rat liver S9 fractions Andreas Schiwy, DE-Aachen |
|
77 | Development of an additive manufactured mouse phantom for quality assurance of a small animal irradiation device Marie F. E. Wegner, DE-Hamburg |
|
32 | Metabolome analysis in vitro in NRK-52e cells might allow the prediction of nephrotoxicity and its mode of action Barbara Birk, DE-Ludwigshafen |
|
260 | Establishment of a model for Equine Grass Sickness: extracorporeal blood perfusion of equine ileum Maria Unterköfler, AT-Vienna |
|
16.1 Specific Endpoints of Toxicity I Tuesday, 25 September 2018 16:00-17:30 |
||
31 | Evaluation of retinoic acid receptor alpha (RARα) interaction of chemicals by combining two techniques to a new screening approach Barbara Birk, DE-Ludwigshafen |
|
35 | Non-animal methods for skin sensitisation testing - is there really a need for integrated testing strategies? David Roberts, GB-Liverpool |
|
118 | Pre-validation of an Acute Inhalation Toxicity Test Using the EpiAirway In Vitro Human Airway Model Silvia Letasiova, SK-Bratislava |
|
121 | The added value of the 90-day repeated dose test for substances of low (sub) acute toxicity for REACH purposes Katy Taylor, GB-London |
|
16.2 Specific Endpoints of Toxicity II Wednesday, 26 September 2018 09:35-11:05 |
||
215 | Impedance spectroscopy as a method to discriminate between all GHS categories for eye irritation in vitro Christian Lotz, DE-Würzburg |
|
247 | Integrating Knowledge Of Carcinogenicity Adverse Outcome Pathways (AOPs) With Experimental Data Steven Kane, GB-Leeds |
|
286 | In vitro methods for identifying substances with endocrine disruption potential Marketa Dvorakova, CZ-Prague |
|
30 | Persistent endocrine-disrupting chemicals found in human follicular fluid stimulate proliferation of granulosa tumor via IGF1R - 3D cell culture model Justyna Gogola, PL-Krakow |
|
17 Stem Cell Models (hiPS, ES, mES, miPS) Tuesday, 25 September 2018 14:00-15:30 |
||
144 | Modelling sporadic Alzheimer's disease using patient derived iPSCs Andras Dinnyes, HU-Godollo |
|
236 | Alternative research methods for challenging disease: human iPS derived Parkinson’s-on-chip Julie Rosser, AT-Vienna |
|
155 | A new approach for animal free carcinogenicity testing using MN as biomarker (PMNvit) Bastian Niklas Hölzel, DE-Aarbergen |
|
165 | Carp Stem Cells Growth on Chorioallantoic Membrane of Fertilized Hen's Egg Mahmoud Galal, EG-Cairo |
|
200 | Modeling sex differences in vitro Judith Lechner, AT-Innsbruck |
|
18 Update on Implementing EU Dir 63/2010 Monday, 24 September 2018 09:35-11:05 |
||
197 | Directive 2010/63/EU – progress, challenges and future directions Susanna Louhimies, BE-Brussels |
|
92 | Transition to animal-free research - on possibilities for phasing out animal experiments and stimulating animal-free innovation Henriette Bout, NL-Den Haag |
|
95 | Understanding and implementation of the 3Rs of animal welfare bodies at German research facilities and universities Carolin Spicher, DE-Munich |
|
16 | Meta-analysis of NTSs ameliorates identification of research areas for 3R development Bettina Bert, DE-Berlin |
|
160 | Severity classification: curse or blessing? Anne Zintzsch, DE-Giessen |
|
242 | Decision making on the possible handling of laboratory animals after a trial Mechthild Ladwig-Wiegard, DE-Berlin |
|
paid advertising |
||
19 Vaccines & The 3Rs: New Methods and Developments (e.g. Batch Release Testing) Monday, 24 September 2018 11:35-13:05 |
||
101 | Human Rabies vaccine glycoprotein G ELISA as an alternative to the challenge test: selection of a candidate method and future strategies Jean Michel Chapsal, BE-Brussels |
|
116 | Development of an in vitro potency assay for Zika Purified Inactivated Vaccine (ZPIV) Stephanie Richard, FR-Marcy l'Etoile |
|
145 | Vaccine batch to vaccine batch comparison by consistency testing (VAC2VAC) Hilde Depraetere, DE-Heidelberg |
|
259 | Bacterially expressed nanobodies can replace secondary antibody production in animals Dirk Görlich, DE-Göttingen |
|
20.1 'Young Scientists' session I Wednesday, 26 September 2018 09:35-11:05 |
||
42 | The hen’s egg test on the chick area vasculosa (HET-CAV) as a test system to evaluate the antimicrobial activity of drugs and formulations Paul Warncke, DE-Jena awarded with the YSTA 2018 |
|
181 | Comparison of Breathing Patterns for Aerosol Inhalation Using an Electro-mechanical Lung Simulator Richard Paštěka, AT-Vienna awarded with the YSTA 2018 |
|
280 | Off-target effects of novel purine-analog phosphonates for anti-cancer therapy Christian Zoschke, DE-Berlin |
|
19 | A dynamic model of the alveolar interface for the study of aerosol deposition Roberta Nossa, IT-Pisa awarded with the YSTA 2018 |
|
53 | Human buffy-coat derived platelet lysate: comparison of single-patient and pooled units for the cultivation of different human cell lines Michelle Hesler, DE-Sulzbach awarded with the YSTA 2018 awarded with the Young Scientist Best Oral Award 2018 for the best oral presentation |
|
97 | Organ-on-a-chip meets traction force microscopy: In situ characterization of forces in 3D micro-tissues Stefanie Fuchs, DE-Stuttgart awarded with the YSTA 2018 |
|
20.2 'Young Scientists' session II Wednesday, 26 September 2018 11:35-13:05 |
||
103 | Co-Cultivation of myofibroblasts and adipocytes provides new insights into hypertrophic scar regeneration Katharina Hörst, DE-Berlin awarded with the YSTA 2018 awarded with the Young Scientist Best Oral Award 2018 for the third best oral presentation |
|
128 | Development of advancing human 3D trabecular meshwork models to assess onset of Glaucoma Sara Tirendi, IT-Genova awarded with the YSTA 2018 |
|
159 | 3Rs in Education - Systematical Evaluation of Simulators for Rats and Mice Melanie Humpenöder, DE-Berlin awarded with the YSTA 2018 |
|
175 | Bioinformatics analysis of IPS cell data to elucidate mechanisms of actions of nephrotoxins Pranika Singh, CH-Basel |
|
246 | SimulRator – Manufacturing a 3D-printed simulator of the rat for laboratory animal training courses Giuliano Mario Corte, DE-Berlin awarded with the YSTA 2018 |
|
251 | Chronic lymphocytic leukemia cells as an in vitro model in preclinical drug evaluation Tijana Markovic, SI-Ljubljana |
|
R1 Round Table I (plenary) International Progress in 3Rs Research Sunday, 23 September 2018 17:35-18:35 |
||
Moderator Erin Hill, ASCCT, US-Gaithersburg Panelists Shujun Cheng, CCARE, CN-Guangzhou & Shanghai Roger Curren, IIVS, US-Gaithersburg Stefanie Schindler, AnimalfreeResearch, CH-Bern |
||
R2 Round Table II (plenary) 3R Centers in Europe - National and Local Centers Monday, 24 September 2018 17:35-18:35 |
||
Moderator Susanna Louhimies, EU, BE-Brussels Panelists Arti Ahluwalia, Centro 3R, IT-Genoa Chantra Eskes, 3RCC, CH-Bern Ian Ragan, NC3R, GB-London Monika Schaefer-Korting, BB3R, DE-Berlin Stephanie Kraemer, ICar3R, DE-Giessen Judith Lechner, MUI Animal Free Research Cluster, AT-Innsbruck |
||
R3 Round Table III (plenary) Applying human 3D models and Multi-Organ-Chips (MOCs) in Industry Tuesday, 25 September 2018 17:35-18:35 |
||
Moderator Winfried Neuhaus, AIT, AT-Vienna Panelists Samuel Constant, Epithelix & Oncotheis, CH-Plan-les-Ouates Helena Kandarova, MatTek, SK-Bratislava (to be confirmed) Jochen Kuehnl, Beiersdorf, DE-Hamburg Robert Landsiedel, BASF, DE-Ludwigshafen Peter Ertl, Vienna University of Technology, AT-Vienna |
||
P1 Poster Session I Monday, 24 September 2018 18:35-20:00 |
||
Survey of the posters with presence of the authors. The titles and authors of this poster session I will be published separately. All posters will be present during all days of the congress. |
||
P2 Poster Session II Tuesday, 25 September 2018 18:35-20:00 |
||
Survey of the posters with presence of the authors. The titles and authors of this poster session II will be published separately. All posters will be present during all days of the congress. |
||